tiprankstipranks
Trending News
More News >
RenovoRx (RNXT)
NASDAQ:RNXT
US Market

RenovoRx (RNXT) Income Statement

Compare
139 Followers

RenovoRx Income Statement

Last quarter (Q3 2025), RenovoRx's total revenue was $266.00K, an increase of Infinity% from the same quarter last year. In Q3, RenovoRx's net income was $-2.91M. See RenovoRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 43.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 43.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.01M$ 11.40M$ 9.95M$ 5.67M$ 3.20M
Depreciation and Amortization
$ 0.00$ 6.00K$ 6.00K$ 9.00K$ 3.20M
EBITDA
$ -10.97M$ -11.39M$ -9.94M$ -5.48M$ 0.00
Operating Income
$ -10.97M$ -11.40M$ -9.95M$ -5.67M$ -3.20M
Other Income/Expenses
$ 2.16M$ 1.16M$ 61.00K$ -653.00K$ -594.00K
Pretax Income
$ -8.81M$ -10.23M$ -9.89M$ -6.32M$ -3.80M
Net Income
$ -8.81M$ -10.23M$ -9.89M$ -6.32M$ -3.80M
Per Share Metrics
Basic EPS
$ -0.37$ -0.50$ -0.54$ -0.40$ -0.25
Diluted EPS
$ -0.37$ -0.50$ -0.54$ -0.40$ -0.25
Weighted Average Shares Outstanding
23.61M 20.58M 18.10M 17.87M 17.32M
Weighted Average Shares Outstanding (Diluted)
23.61M 20.58M 18.10M 17.87M 17.32M
Currency in USD

RenovoRx Earnings and Revenue History